Latest News and Press Releases

- Approval establishes first clinical authorization outside Israel and initiates post-market surveillance program - - First-in-kind technology delivers intra-tumoral alpha-emitting radiotherapeutics,...

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, BCTXL) (TSX: BCT) (“BriaCell”), a clinical-stage...

Stoked Bio, a Canadian biotech company, will lead the development of Enterololin, a promising antibiotic, as a potential therapeutic for Crohn’s disease.

Unnatural Products Announces Licensing Agreement with Novartis to Develop Macrocyclic Peptide Therapeutics

NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), a leading global consumer packaged goods company and the fourth-largest craft beer brewer in the United...

SAN FRANCISCO and LOS ANGELES and KIGALI, Rwanda, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Bio Usawa, a leader in expanding global access to biopharmaceuticals, and Nanoly Bioscience, a pioneer in chemical...

WILMINGTON, Del., Feb. 17, 2026 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a wireless, video, and AI technology research and development company, today announced that the company has...

Dubai, Vereinigte Arabische Emirate, 13. Februar 2026 – PU Prime, eine weltweit führende Multi-Asset-Broker-Gruppe, gibt stolz bekannt, dass ihrem in Dubai ansässigen Unternehmen offiziell eine...

Dubaï, Émirats arabes unis, 13 février 2026  – PU Prime, un groupe de courtage multi-actifs de premier plan mondial, est fier d'annoncer que son entité basée à Dubaï a officiellement obtenu une...

PU Prime has announced that its Dubai-based entity has been officially granted a licence (No. 20200000388) by the UAE Capital Market Authority (CMA).